Unfavourable benefit–risk ratio for the active substance fenspiride identified from non-clinical studies; an EU review procedure initiated. Potential effects: serious adverse reactions, threat to health or life.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product; return it to the pharmacy or the marketing authorisation holder; contact a physician if adverse effects occur.
Temporary prohibition on placing Eurefin on the market and suspension of distribution of all batches with immediate enforceability; notification of relevant authorities and initiation of the EU review...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related